Crinetics Pharmaceuticals, Inc. Deferred Tax Assets, Operating Loss Carryforwards, Foreign
Crinetics Pharmaceuticals, Inc. (CRNX) had Deferred Tax Assets, Operating Loss Carryforwards, Foreign of $14.20 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign · last filed 2026-02-26
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $14.20M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $3.10M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $1.70M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $1.30M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Foreign |
|---|---|
| 2025-12-31 | $14.20M 10-K · filed 2026-02-26 |
| 2024-12-31 | $3.10M 10-K · filed 2025-02-27 |
| 2023-12-31 | $1.70M 10-K · filed 2024-02-28 |
| 2022-12-31 | $1.30M 10-K · filed 2023-02-28 |
| 2021-12-31 | $1.30M 10-K · filed 2022-03-30 |
| 2020-12-31 | $1.60M 10-K · filed 2021-03-30 |
| 2019-12-31 | $400.00K 10-K · filed 2020-03-09 |
| 2018-12-31 | $100.00K 10-K · filed 2019-03-13 |